CT
CytomX Therapeutics Inc
🇩🇪XSTU.6C1GermanyHealthcare
€2.34EURdown -0.01 (-0.43%)OpenEnd of day9:12 AM
Price€2.34-0.01 (-0.43%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US23284F1057
- CUSIP
- Not reported
Company
- Employees
- 69
- Headquarters
- South San Francisco, United States
- Website
- https://www.cytomx.com
- CEO
- Dr. Sean A. McCarthy DPHIL
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- 0.36%
Fundamentals (LTM)
- Revenue
- $18.3M-87.03%down year on year
- Net income
- -$79.65M-266%down year on year
- Gross margin
- 95.84%-3.64%down year on year
- Free cash flow
- -$82.48M-6.18%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.